DLH Announces Filing of New Shelf Registration Statement
June 04 2020 - 9:08AM
DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the
“Company”), a leading provider of innovative healthcare
services and solutions to federal agencies, today announced that it
has filed a new shelf registration statement on Form S-3 with the
United States Securities and Exchange Commission (“SEC”) to replace
its previous shelf registration statement, which had expired. The
registration statement was filed on June 2, 2020 and will become
effective upon successful review by the SEC.
If and when it is declared effective, the
registration statement will allow DLH to offer and sell, from time
to time, up to $50 million of its equity securities; however, there
are no current plans to do so. The Company did not issue any
securities under the expired registration statement. Like many
issuers, DLH filed the shelf registration statement to provide it
with flexibility to access capital markets if circumstances arise
that would make the sale of securities advantageous to the
Company.
These securities may not be sold, nor may offers
to buy be accepted, prior to the time the registration statement
becomes effective. Following the effectiveness of the shelf
registration statement, DLH may periodically offer one or more of
the registered securities in amounts, at prices, and on terms to be
announced when, and if, the securities are offered. The terms of
any securities offered under the registration statement, and the
intended use of the net proceeds resulting therefrom, will be
established at the times of the offerings and will be described in
prospectus supplements filed with the SEC at the times of the
offerings.
This press release is not an offer to sell or a
solicitation of an offer to buy, nor shall there be any sale of
securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction. Any offer of securities covered by the
registration statement may be made solely by means of the
prospectus included in the registration statement and a related
prospectus supplement containing specific information about the
terms of any such offering.
About DLHDLH (NASDAQ:DLHC)
serves federal government clients throughout the United States and
abroad delivering technology enabled solutions in key health and
human services programs. The Company's seven core competencies
include secure data analytics, clinical trials and laboratory
services, case management, performance evaluation, system
modernization, operational logistics and readiness, and strategic
digital communications. DLH has over 1,950 employees serving
numerous government agencies. For more information, visit the
corporate website at www.dlhcorp.com
Safe Harbor Statement under the Private
Securities Litigation Reform Act of 1995:This press
release may contain forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. These
statements relate to future events or DLH`s future financial
performance. Any statements that refer to expectations,
projections or other characterizations of future events or
circumstances or that are not statements of historical fact
(including without limitation statements to the effect that the
Company or its management “believes”, “expects”, “anticipates”,
“plans”, “intends” and similar expressions) should be considered
forward looking statements that involve risks and uncertainties
which could cause actual events or DLH’s actual results to differ
materially from those indicated by the forward-looking statements.
Forward-looking statements in this release include, among others,
statements regarding benefits of the acquisition, estimates of
future revenues, operating income, earnings, earnings per share,
backlog, and cash flows. These statements reflect our belief and
assumptions as to future events that may not prove to be accurate.
Our actual results may differ materially from such forward-looking
statements made in this release due to a variety of factors,
including: the outbreak of the novel coronavirus (“COVID-19”),
including the measures to reduce its spread, and its impact on the
economy and demand for our services, are uncertain, cannot be
predicted, and may precipitate or exacerbate other risks and
uncertainties; the risk that we will not realize the anticipated
benefits of an acquisition; the challenges of managing larger and
more widespread operations resulting from the acquisition; contract
awards in connection with re-competes for present business and/or
competition for new business; compliance with new bank financial
and other covenants; changes in client budgetary priorities;
government contract procurement (such as bid protest, small
business set asides, loss of work due to organizational conflicts
of interest, etc.) and termination risks; the ability to
successfully integrate the operations of future acquisitions; and
other risks described in our SEC filings. For a discussion of such
risks and uncertainties which could cause actual results to differ
from those contained in the forward-looking statements, see “Risk
Factors” in the Company’s periodic reports filed with the SEC,
including our Annual Report on Form 10-K for the fiscal year ended
September 30, 2019, as well as interim quarterly filings
thereafter. The forward-looking statements contained herein are not
historical facts, but rather are based on current expectations,
estimates, assumptions and projections about our industry and
business. Such forward-looking statements are made as of the
date hereof and may become outdated over time. The Company does not
assume any responsibility for updating forward-looking statements,
except as may be required by law.
CONTACTS:
INVESTOR RELATIONS |
Contact: Chris Witty |
Phone: 646-438-9385 |
Email: cwitty@darrowir.com |
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jun 2024 to Jul 2024
DLH (NASDAQ:DLHC)
Historical Stock Chart
From Jul 2023 to Jul 2024